Acadian Asset Management
FATE icon

Acadian Asset Management’s Fate Therapeutics FATE Stock Holding History

Acadian Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.94M Buy
4,120,200
+1,188,307
+41% +$1.45M 0.01% 719
2025
Q4 		$2.88M Buy
2,931,893
+221,659
+8% +$266K ﹤0.01% 818
2025
Q3 		$3.41M Buy
2,710,234
+250,280
+10% +$270K 0.01% 749
2025
Q2 		$2.75M Sell
2,459,954
-13,611
-0.6% -$15.8K 0.01% 743
2025
Q1 		$1.95M Buy
2,473,565
+999,773
+68% +$1.23M 0.01% 758
2024
Q4 		$2.43M Sell
1,473,792
-128,328
-8% -$323K 0.01% 719
2024
Q3 		$5.61M Sell
1,602,120
-406,742
-20% -$1.58M 0.02% 476
2024
Q2 		$6.59M Buy
2,008,862
+294,738
+17% +$1.29M 0.02% 435
2024
Q1 		$12.6M Sell
1,714,124
-567,047
-25% -$3.51M 0.04% 260
2023
Q4 		$8.53M Buy
2,281,171
+131,574
+6% +$311K 0.03% 328
2023
Q3 		$4.55M Buy
2,149,597
+1,236,680
+135% +$4.1M 0.02% 463
2023
Q2 		$4.34M Buy
+912,917
New +$5.04M 0.02% 493
2018
Q2 		– Sell
-10,347
Closed -$101K – 1748
2018
Q1 		$101K Buy
+10,347
New +$99.1K ﹤0.01% 1211
2016
Q1 		– Sell
-1,038
Closed -$3K – 1400
2015
Q4 		$3K Buy
+1,038
New +$4.36K ﹤0.01% 1335
2015
Q3 		– Sell
-306
Closed -$2K – 1336
2015
Q2 		$2K Buy
+306
New +$1.83K ﹤0.01% 1316

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management's FATE Position: Q1 2026 in Review

Acadian Asset Management increased its Fate Therapeutics (FATE) stake by 41% in Q1 2026, buying an estimated $1.45M and bringing the position to 4,120,200 shares worth $4.94M. The position accounts for 0.01% of the portfolio, ranked #719.

Acadian Asset Management first reported a position in FATE in Q2 2015 and has held it in 15 quarters since. The position peaked at $12.6M in Q1 2024. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • Acadian Asset Management held 4,120,200 shares of Fate Therapeutics worth $4.94M as of Q1 2026.
  • Acadian Asset Management bought 1,188,307 Fate Therapeutics shares in Q1 2026, an estimated $1.45M.
  • Fate Therapeutics made up 0.01% of Acadian Asset Management's portfolio in Q1 2026, its #719 holding.
  • Acadian Asset Management first reported a position in Fate Therapeutics in Q2 2015 and has held it in 15 quarters since.
  • Acadian Asset Management's Fate Therapeutics position peaked at $12.6M in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.